The largest database of trusted experimental protocols

Anti irak1

Manufactured by Santa Cruz Biotechnology
Sourced in United States

Anti-IRAK1 is a laboratory reagent used for the detection and quantification of IRAK1 (Interleukin-1 Receptor-Associated Kinase 1) in various biological samples. It is a primary antibody that specifically binds to IRAK1, a key signaling molecule involved in the inflammatory response. The core function of Anti-IRAK1 is to enable researchers to analyze the expression and/or activity of IRAK1 in their experiments.

Automatically generated - may contain errors

15 protocols using anti irak1

1

Western Blot Analysis of Inflammatory Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blot was performed as described previously (5 (link),13 (link),33 (link)). Briefly, the cellular proteins were separated by SDS-polyacrylamide gel electrophoresis and transferred onto Hybond ECL membranes (Amersham Pharmacia, Piscataway, NJ). The ECL membranes were incubated with the appropriate primary antibody anti-IRAK1 (sc-7883, Santa Cruz Biotechnology), anti-TRAF6 (sc-7221, Santa Cruz Biotechnology), and anti-IκBα, respectively, followed by incubation with peroxidase-conjugated secondary antibodies (Cell Signaling Technology, Inc.) and analysis by the ECL system (Amersham Pharmacia, Piscataway). The signals were quantified using the G:Box gel imaging system by Syngene (Syngene, USA, Fredrick, MD).
+ Open protocol
+ Expand
2

Immunofluorescence Staining of IRAK-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were washed with PBS and fixed with 4% paraformaldehyde for 20 min at room temperature. Cells were blocked with 5% bovine serum albumin (Beyotime Institute of Biotechnology) and 0.1% Triton X-100 for 1 h and incubated with anti-IRAK-1 (Santa Cruz Biotechnology, Inc.) at 4°C overnight. Cells were washed with PBS and incubated with goat anti-rabbit IgG-CFL 555 (Santa Cruz Biotechnology, Inc.) for 1 h at room temperature. Cells were washed with PBS and stained with DAPI for 15 min at room temperature. Then, cells were washed with PBS and observed under a light microscope (magnification, ×100, BH3-MJL; Olympus Corporation).
+ Open protocol
+ Expand
3

Antibodies and Inhibitors for Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibody against linear ubiquitin chains and RBCK1 were described(13 (link)). Other antibodies were purchased as follows: anti-IKKβ, anti-phospho-IKKβ, anti-IκBα, anti-phospho-IκBα anti-CARD11 from Cell Signaling Technologies; anti-ubiquitin (P4D1), polyclonal anti-NEMO/IKKγ (FL–419) anti-β-actin, anti-IRAK1, anti-MALT1, anti-A20 from Santa Cruz Biotechnology; anti-RNF31, anti-SHARPIN, anti-myc-tag from Abcam; monoclonal anti-NEMO/IKKγ from BD Pharmingen; anti-human IgM from Jackson ImmunoResearch Lab. Isotype control antibodies were obtained from the same company as each experimental antibody. Secondary HRP-conjugated antibodies were obtained from GE Healthcare.
The Myc-tag elution peptide and Etoposide were obtained from Sigma. The IMiD compound lenalidomide was obtained from Celgene Corporation. The IKKβ inhibitor MLN120B was obtained from Millennium Pharmaceuticals. The BTK inhibitor (ibrutinib) was obtained from Pharmacyclics, Inc. The MALT1 inhibitor Z-VRPR-FMK was obtained from Enzo Life Sciences. Tissue culture grade DMSO vehicle control was obtained from Sigma-Aldrich.
+ Open protocol
+ Expand
4

Immunoblotting Analysis of Mouse Lung Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse lung tissue homogenates were separated by electrophoresis on 10 to 15% SDS-PAGE, transferred on PVDF membranes (Merck Millipore, Burlington, MA, USA), blocked in 5% of non-fat dry milk, and incubated with primary antibodies including anti-CitH3 (1:1000, citrulline R2 + R8 + R17, Abcam, Cambridge, UK), anti-TRAF6 (1:1000, Santa Cruz), anti-IRAK-1 (1:1000, Santa Cruz), anti-PAD4 (1:1000, Abcam), anti-HMGB1 (1:1000, Abcam) or anti-β-actin antibodies (1:5000, Sigma-Aldrich) at 4 °C for 18 h. After washing, the membranes were incubated with HRP-conjugated secondary antibodies (1:10,000, Jackson Immunoresearch, West Grove, PA, USA) at RT for 2 h. Signal expression of protein-antibody complexes was detected by ECL system (Amersham Pharmacia Biotech, Buckinghamshire, UK) and visualized with Biospectrum imaging system (UVP, Upland, CA, USA). Relative protein expression levels were measured by Image J (National Institute of Health, Bethesda, MD, USA).
+ Open protocol
+ Expand
5

IRAK1 Signaling Pathway Immunoprecipitation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed in an endogenous lysis buffer (20 mM Tris-HCl, pH 7.6, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 30 mM NaF, and 2 mM sodium pyrophosphate) supplemented with complete protease inhibitor cocktail (Roche), phosphatase inhibitor tablet (Roche), 1 mM DTT, 1 mM Na3VaO4, and 1 mM PMSF. Samples were cleared by centrifugation at 14,000 rpm, and protein concentration was measured using the BCA Protein Assay kit (Thermo Fisher Scientific). For immunoblotting, total proteins were separated on 4–12% SDS–polyacrylamide gels and transferred to nitrocellulose membranes. For immunoprecipitation experiments, samples were first precleared with Protein G Dynabeads (Invitrogen) for 60 min. Cleared lysates were incubated overnight with an anti-IRAK1 antibody (Santa Cruz Biotechnology, Inc.), followed by Protein G Dynabeads for an additional 2 h at 4°C. Immunoprecipitates were washed five times with 0.5 M NaCl lysis buffer, separated by SDS-PAGE, transferred to nitrocellulose, and analyzed by immunoblotting. Antibodies used were as follows: anti-IKKβ, anti–phospho-IKKβ, anti–phospho-IRAK4 (pThr-345/Ser-346), and anti-IRAK4 (total) from Cell Signaling Technologies; and anti–β-actin and anti-IRAK1 from Santa Cruz Biotechnology, Inc. Secondary HRP-conjugated antibodies were obtained from GE Healthcare.
+ Open protocol
+ Expand
6

Immunoprecipitation and Immunoblotting Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peroxidase-conjugated anti-rabbit and anti-mouse antibodies were purchased from Millipore (Billerica, MA, USA). Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine serum (FBS), fetal calf serum, and lipofectamine and PLUS reagents were purchased from Life Technologies (Grand Island, NY, USA). Anti-Myc, anti-GAPDH, anti-TAK1, anti-TRAF6 and anti-IRAK1 antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Polyclonal anti-RCAN1 antibodies were purchased from ECM Biosciences (Versailles, KY, USA) and Santa Cruz Biotechnology. Anti-LRRK2, anti-phospho-LRRK2 (Ser935), and anti-phospho-TAK1 (Thr187) antibodies were purchased from Abcam (Cambridge, MA, USA) and Cell Signaling Technology (Beverly, MA, USA), respectively. Polyclonal and monoclonal anti-HA antibodies were purchased from Abnova (Tebu, France) and Covance (Powhatan, VA, USA), respectively. Protein A-Sepharose beads and glutathione sepharose 4B were purchased from GE Healthcare Life Science (Piscataway, NJ, USA). Enhanced chemiluminescence (ECL) reagent and [γ-32P] ATP were purchased from Perkin Elmer Life Sciences (Downers Grove, IL, USA). MG132 was purchased from A.G. Scientific (San Diego, CA, USA). Human recombinant IL-1β was purchased from Sigma (St. Louis, MO, USA).
+ Open protocol
+ Expand
7

Isolation and Culture of Splenic Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
Highly purified LPS from Escherichia coli O111:B4 and loxoribine (Lxrb) were from Invivogen (San Diego, CA). The following Abs were used: anti-phospho (p)-p38 and anti-p38, anti-p-IRAK1, anti-p-p65 and anti-p65 (Cell Signaling Technology, Danvers, MA), anti-IRAK1, anti-IRAK-M, anti-Tollip, anti-pERK1/2 and anti-ERK1/2, anti-pJNK1/2 and anti-JNK1/2, and anti-tubulin (Santa Cruz Biotechnology, Dallas, Texas). Splenic MΦs were obtained by differentiation of splenocytes with CSF-1-containing L929-conditioned medium [78 (link)]. This procedure led to a significant enrichment of CD11b+F4/80+ splenic MΦs (Fig. S3) [78 (link)]. Splenocytes were plated into 10-cm tissue culture dishes and cultured for 7 days in RPMI medium supplemented with 2 mM L-glutamine, 100 u/ml penicillin, 100 μg/ml streptomycin, 10 mM HEPES, 10% FBS (Atlanta Biologicals, Flowery Branch, GA), 5 × 10−5 M β-mercaptoethanol (complete RPMI), and 25% L929-conditioned medium. Following trypsin treatment (0.5%), cells were resuspended in complete RPMI and used for experiments.
+ Open protocol
+ Expand
8

Regulation of IRF7 Signaling Pathway

Check if the same lab product or an alternative is used in the 5 most similar protocols
CpGA (ODN2116), CpGB (ODN2006) and R848 were purchased from Invivogen. The following antibodies were used for immunoblotting: anti-MYC, anti-IRF7, and anti-IRAK1 (Santa Cruz Biotech); anti-TLR7 (Abcam); anti-MyD88 and anti-TLR9 (eBioscience); anti-STAT1, anti-NCOR2, anti-HDAC1, anti-HDAC2, anti-HDAC3, anti-HDAC4, anti-HDAC6, anti-HDAC7, anti-pIKKα/β, anti-pIκBα, anti-IκBα, anti-pJNK, anti-pp38, anti-TBK1, anti-pTBK1 and anti-pERK (Cell Signaling Technologies); and anti-GAPDH (Sigma).
NE-PER Nuclear and Cytoplasmic Extraction Reagents (Pierce) was used to investigate nuclear translocation of IRF7 as per the manufacturer’s instructions. MYC inhibitor (c-Myc Inhibitor II - CAS 413611-93-5) was purchased from CalBiochem. HDAC inhibitors, valproic acid (VPA) was purchased from Invivogen.
+ Open protocol
+ Expand
9

Immunohistochemical Analysis of IRAK1, Vimentin, and IL6

Check if the same lab product or an alternative is used in the 5 most similar protocols
Harvested tissues were fixed in 10% formalin solution, (HT501128, Sigma-Alrich). Tissues were dehydrated and embedded in paraffin. Paraffin-embedded tissue sections (5 μm thick) were cut, deparaffinized and rehydrated, and antigens were retrieved using pH 6 sodium citrate. The sections were then incubated in 0.06% hydrogen peroxide at room temperature, to block endogenous peroxidase. The slides were incubated overnight with anti-IRAK1 (catalogue number: sc-7883, 1:100 dilution), anti-vimentin (catalogue number: sc-6260, 1:500 dilution) from Santa Cruz Biotechnology and anti-IL6 from Abcam (Cambridge, MA; catalogue number: ab1543670, 1:1000 dilution) overnight, followed by 60 min incubation with anti-mouse IgG/rabbit IgG (catalogue number: PK-6200, 1:2000 dilution) and 60 min of Avidin DH and Biotinylated Horseradish Peroxidase H. ImmPACT DAB Peroxidase Substrate (catalogue number: SK-4105) was used as the chromogen. Vector Hematoxylin QS (H-3404) was used as counterstain.
+ Open protocol
+ Expand
10

TLR2 Signaling Pathway Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following Abs were used: anti-phospho (p)-IRAK1, anti-IRAK1, anti-p65 NF-κB (Santa Cruz Biotechnology, Santa Cruz, CA); anti-p-IRAK-4, anti-p-p38, anti-p-ERK1/2, anti-ERK1/2, anti-p38, anti-IκB-α, anti-p-p65, anti-p-IRF3, and anti-β-tubulin (Cell Signaling Technology, Inc., Danvers, MA). Pam3Cys, S-[2,3-bis(palmitoyloxy)-(2-RS)-propyl]-N-palmitoyl-(R)-Cys-Ser-Lys4-OH], was purchased from InvivoGen (San Diego, CA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!